GlassScriptPhysician profile
Mark A Ventura
NPI 1679619654
$684.27
in general payments reported to CMS, 2019-2025
12 companies · $461 in 2025
The $461 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.58 · 2021: $19.07 · 2023: $123 · 2024: $55.88 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $144.22 | 2024-2025 | Gemtesa |
| Procept Biorobotics Corporation | $123.39 | 2023 | Aquabeam Robotic System |
| Abbvie INC. | $106.38 | 2024-2025 | |
| Dentsply Ih Ab | $55.44 | 2025 | Lofric |
| Telix Pharmaceuticals | $47.47 | 2025 | Illuccix |
| Teleflex LLC | $45.80 | 2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $37.93 | 2021-2025 | Axonics |
| Coloplast Corp | $37.75 | 2025 | |
| Laborie Medical Technologies Corp. | $26.04 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astrazeneca Pharmaceuticals LP | $24.58 | 2020 | |
| Cook Medical LLC | $17.75 | 2025 | Litho 150 |
| Calyxo, INC. | $17.52 | 2025 | Cvac Aspiration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ventura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.